Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Laura Biganzoli

Has grant

Azienda Usl Toscana Centro

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cell Biology Cell Biology professors in Italy

Recent Grants

Grant: Close

The TOUCH trial: a unique opportunity of studying the biology of HER2+ and ER+ breast cancer

Open Date: 2024-10-01

Close Date: 2025-09-30

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (17)

Andreas Mueller

Dr. med.; Head of Breast Center

SWITZERLAND

View details

Carmen Criscitiello

IRCCS Humanitas Research Hospital

ITALY

View details

Aglaia Schiza

Associate Professor (Docent, non-tenured and unsalaried title in the Swedish system)

Uppsala University

SWEDEN

View details

Sophie Pilleron

FNR ATTRACT Fellow, group leader

University of Oxford

UNITED KINGDOM

View details

Antonis Valachis

Örebro university

SWEDEN

View details

Nicola Tinari

Professore Associato

University of Chieti-Pescara

ITALY

View details

Kwok-Leung Cheung

University of Nottingham School of Medicine

UNITED KINGDOM

View details

SIMONA PISEGNA

Sapienza University of Rome

ITALY

View details

Giorgio Mustacchi

Università degli Studi di Torino

ITALY

View details

Paolo Manca

Research Scholar

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Icro Meattini

Associate Professor

University of Florence

ITALY

View details

Emanuela Lucci Cordisco

Ricercatore Confermato

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

View details

Giampaolo Bianchini

Head Breast Cancer Group

IRCCS Ospedale San Raffaele

ITALY

View details

Daniela Bernardi

Associate Professor of Radiology

Humanitas University

ITALY

View details

Vanesa GREGORC

Candiolo Cancer Institute

ITALY

View details

Chiara Cremolini

University Hospital of Pisa

ITALY

View details

Davide Franceschini

IRCCS Humanitas Research Hospital

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laura Biganzoli

Research Interests

Explore related searches

Recent Grants

Articles (20)

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)

ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial

The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer

Prognostic role of thymidine kinase 1 activity in hormone receptor positive metastatic breast cancer. A systematic review and meta-analysis

The genomic landscape of HER2 negative metastatic breast cancer with loss of estrogen and progesterone receptors

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.

Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study

Ensuring access to multidisciplinary care in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 4).

Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendations.

Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.

The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report.

Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer.

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients

Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.

Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.

Collaborators (17)

Andreas Mueller

Carmen Criscitiello

Aglaia Schiza

Sophie Pilleron

Antonis Valachis

Nicola Tinari

Kwok-Leung Cheung

SIMONA PISEGNA

Giorgio Mustacchi

Paolo Manca

Icro Meattini

Emanuela Lucci Cordisco

Giampaolo Bianchini

Daniela Bernardi

Vanesa GREGORC

Chiara Cremolini

Davide Franceschini

Make your next move.